Article Text

Download PDFPDF
Be more sensitive, please – using cardiac troponin assays for diagnosing AMI
  1. Johannes Tobias Neumann1,2,
  2. Stefan Blankenberg1,2,
  3. Dirk Westermann1,2
  1. 1Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany
  2. 2German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany
  1. Correspondence to Dr Dirk Westermann, Department of General and Interventional Cardiology, University Heart Center Hamburg, Martinistr. 52, Hamburg 20246, Germany; d.westermann{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The use of high-sensitive troponin is recommended by international guidelines to diagnose or to rule out acute myocardial infarction (AMI). The 99th percentile in combination with an absolute or relative change (baseline and 3 h later) of troponin has been suggested to triage patients in the emergency department. For ruling in, two distinct pathways are proposed: when the first measurement is below the 99th percentile of the troponin assay and the second one is above it, an relative delta of 50% is required to diagnose AMI. When both measurements are above the 99th percentile, a relative delta of 20% is required. For ruling out, both values should be below the 99th percentile. While this approach is used in clinical routine, the experience with newer more sensitive troponin assays is limited. Nevertheless, more sensitive assays may offer better performance, therefore limiting time until the final diagnosis can be made. In this view, different algorithms using different troponin assays have been reported and are represented in the current European Society of Cardiology (ESC) guidelines.1 Importantly, each individual troponin assay has a different sensitivity and requires individual cut-off concentrations to rule in or rule out AMI.2 That …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles